Table 1 Patient characteristics
Characteristic | RAE (n = 24) | Non-RAE (n = 30) | p value |
|---|---|---|---|
Age (years) | 59.0 ± 11.8 | 59.3 ± 8.9 | 0.9 |
Sex (n) | 0.15 | ||
Male | 15 (62.5%) | 24 (80%) | |
Female | 9 (37.5%) | 6 (20%) | |
BMI kg/m2 | 23.1 ± 2.8 | 23.4 ± 3.3 | 0.74 |
Affected kidney (n) | 0.76 | ||
Right | 13 (54.2%) | 15 (50%) | |
Left | 11 (44.8%) | 15 (50%) | |
Tumor size (cm) | 11.1 ± 3.5 | 7.9 ± 2.7 | 0.001* |
Clinical T stage (n) | 0.91 | ||
T3a | 9 (37.5%) | 10 (33.3%) | |
T3b | 13 (54.2%) | 18 (60%) | |
T3c | 2 (8.3%) | 2 (6.7%) | |
Thrombus level (Mayo) | 0.83 | ||
0 | 6 (25%) | 8 (26.7%) | |
I | 9 (37.5) | 7 (23.3%) | |
II | 6 (25%) | 9 (30%) | |
III | 2 (8.3%) | 4 (13.3%) | |
IV | 1 (4.2%) | 2 (6.7%) | |
NYHA classification | 0.56 | ||
I | 16 (66.7%) | 16 (53.3%) | |
II | 7 (29.1%) | 13 (43.3%) | |
III | 1 (4.2%) | 1 (3.4%) | |
ASA score | 0.81 | ||
I | 1 (4.2%) | 1 (3.4%) | |
II | 8 (33.3%) | 14 (46.6%) | |
III | 14 (58.3%) | 14 (46.6%) | |
IV | 1 (4.2%) | 1 (3.4%) | |